Nihar Info Global Limited has announced a major corporate overhaul, including a preferential issue of 1.17 million equity shares and 2 million convertible warrants. The board also approved the divestment of two subsidiaries, Life 108 Healthcare and Beastbells Media, to a related party. Additionally, the company reshuffled its board, appointing a new Independent Director while noting the retirement of another. Shareholders are advised to watch for the upcoming Annual General Meeting on September 30, 2026, where these resolutions will face member voting.
Nihar Info Global Announces Capital Raise and Subsidiary Divestment
Nihar Info Global to issue 1.17 million equity shares and 2 million convertible warrants.
Company to divest stakes in Life 108 Healthcare and Beastbells Media to a Director.
Reader Takeaway: Capital infusion via dilution, alongside strategic divestment, awaits shareholder approval at the upcoming AGM.
What just happened
Nihar Info Global Ltd's board of directors met on August 31, 2026, to authorize a series of strategic moves. The company plans a preferential issue of securities: 1,170,000 equity shares to non-promoter investors and 2,000,000 convertible warrants to promoters. Simultaneously, the company will divest its 51.43% stake in Life 108 Healthcare Private Limited and 99% of Beastbells Media Private Limited to Director Mrs. Vijaya Lakshmi Boda.
Why this matters
The capital raise signals an effort to bolster liquidity, though it will result in equity dilution for current shareholders. The divestment of the two subsidiaries, which is classified as a related party transaction, effectively streamlines the firm’s portfolio. Shareholders hold the final say, with approvals required at the 32nd Annual General Meeting scheduled for September 30, 2026.
Governance and Board Updates
Mr. Annapantula Seetarama Murthy joins the board as an Additional Independent Director for a five-year tenure. He replaces Mr. Ajit Kumar Nagrani, who retired following the conclusion of his second term. The Nomination and Remuneration Committee has been reconstituted to reflect these changes.
Risks to watch
Investors should monitor the dilution impact on earnings per share. Furthermore, the divestment of subsidiaries to a director requires careful scrutiny to ensure valuation transparency and alignment with corporate governance standards. The warrants carry an 18-month exercise window; failure to convert will result in the forfeiture of paid-in capital.